enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. SSRI Alternatives for Depression & Anxiety - AOL

   www.aol.com/ssri-alternatives-depression-anxiety...

   The world of depression treatment options is vast, varied and confusing at times. So many antidepressant medications, so many types of therapy, so many acronyms and so much information.

3. Your Guide to the 6 Most Common Types of Depression ... - AOL

   www.aol.com/6-types-depression-medications...

   Medications for Depression: An Overview. Antidepressants are a class of medications used very commonly to treat depression. In fact, nearly 13 percent of people 12 and over in the U.S. used ...

4. N-Methyl-2-pyrrolidone - Wikipedia

   en.wikipedia.org/wiki/N-Methyl-2-pyrrolidone

   NMP is produced industrially by a typical ester-to-amide conversion, by treating gamma-butyrolactone with methylamine. Alternative routes include the partial hydrogenation of N-methylsuccinimide and the reaction of acrylonitrile with methylamine followed by hydrolysis. About 200,000 to 250,000 tons are produced annually. [3]

5. Psychiatric medication - Wikipedia

   en.wikipedia.org/wiki/Psychiatric_medication

   Psychiatric disorders, including depression, psychosis, and bipolar disorder, are common and gaining more acceptance in the United States. The most commonly used classes of medications for these disorders are antidepressants, antipsychotics, and lithium. Unfortunately, these medications are associated with significant neurotoxicities.

6. Multidisciplinary Association for Psychedelic Studies

   en.wikipedia.org/wiki/Multidisciplinary...

   Included in MAPS' research efforts are MDMA (methylenedioxymethamphetamine) for the treatment of posttraumatic stress disorder (PTSD); LSD and psilocybin for the treatment of anxiety, cluster headaches, and depression associated with end-of-life issues; ibogaine for the treatment of opiate addiction, ayahuasca for the treatment of drug ...

7. STAR*D - Wikipedia

   en.wikipedia.org/wiki/STAR*D

   Sequenced Treatment Alternatives to Relieve Depression (STAR*D) was a collaborative study on the treatment of depression, funded by the National Institute of Mental Health. Its main focus was on the treatment of depression in patients where the first prescribed antidepressant proved inadequate.